| Style | Citing Format |
|---|---|
| MLA | Nabizadeh F, Naser Moghadasi A. "Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder." Current Journal of Neurology, vol. 22, no. 2, 2023, pp. 140-143. |
| APA | Nabizadeh F, Naser Moghadasi A (2023). Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder. Current Journal of Neurology, 22(2), 140-143. |
| Chicago | Nabizadeh F, Naser Moghadasi A. "Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder." Current Journal of Neurology 22, no. 2 (2023): 140-143. |
| Harvard | Nabizadeh F, Naser Moghadasi A (2023) 'Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder', Current Journal of Neurology, 22(2), pp. 140-143. |
| Vancouver | Nabizadeh F, Naser Moghadasi A. Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder. Current Journal of Neurology. 2023;22(2):140-143. |
| BibTex | @article{ author = {Nabizadeh F and Naser Moghadasi A}, title = {Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder}, journal = {Current Journal of Neurology}, volume = {22}, number = {2}, pages = {140-143}, year = {2023} } |
| RIS | TY - JOUR AU - Nabizadeh F AU - Naser Moghadasi A TI - Eculizumab in the Treatment of Neuromyelitis Optica Spectrum Disorder JO - Current Journal of Neurology VL - 22 IS - 2 SP - 140 EP - 143 PY - 2023 ER - |